A new systematic review reveals promising results for oncolytic viral therapy in treating nonmelanoma skin cancers and ...

They say these low-cost, high-impact viruses are showing promise in clinical trials – there are around 60 currently under way ...

Oncolytic virus therapy is emerging as a low-cost, targeted cancer treatment. With over 60 trials in China, scientists see ...

Oncolytic virus therapy is not a new discovery, but it may now be positioned as the next major breakthrough in cancer treatment following the success of checkpoint inhibitors in immunotherapy.

TILT Biotherapeutics’ oncolytic viruses enable solid tumor T cell therapy and checkpoint-inhibiting antibodies. T cell therapies, in which white blood cells are manipulated and propagated in the ...

CAR-T cell therapy is a breakthrough in cancer immunotherapy. The treatment is available in India at a fraction of the cost abroad. Among the many emerging treatments for cancer, there's one called ...

The therapy, which uses an engineered herpes ... The study not only challenges the US and Japan’s dominance in oncolytic virus research, it also pivots the global fight against cancer towards ...

Daiichi Sankyo has launched its oncolytic virus therapy Delytact in Japan – its first world market – as a treatment for malignant glioma, an aggressive form of brain cancer. Delytact ...